Fennec Pharmaceuticals (FENC) EBIAT: 2011-2025
Historic EBIAT for Fennec Pharmaceuticals (FENC) over the last 15 years, with Sep 2025 value amounting to -$638,000.
- Fennec Pharmaceuticals' EBIAT rose 88.88% to -$638,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.9 million, marking a year-over-year decrease of 512.53%. This contributed to the annual value of -$436,000 for FY2024, which is 97.28% up from last year.
- Latest data reveals that Fennec Pharmaceuticals reported EBIAT of -$638,000 as of Q3 2025, which was up 79.76% from -$3.2 million recorded in Q2 2025.
- In the past 5 years, Fennec Pharmaceuticals' EBIAT ranged from a high of $12.8 million in Q1 2024 and a low of -$10.3 million during Q4 2022.
- For the 3-year period, Fennec Pharmaceuticals' EBIAT averaged around -$1.9 million, with its median value being -$2.7 million (2023).
- Within the past 5 years, the most significant YoY rise in Fennec Pharmaceuticals' EBIAT was 312.11% (2024), while the steepest drop was 207.18% (2024).
- Quarterly analysis of 5 years shows Fennec Pharmaceuticals' EBIAT stood at -$4.2 million in 2021, then slumped by 89.66% to -$10.3 million in 2022, then surged by 74.04% to -$2.7 million in 2023, then grew by 25.99% to -$2.0 million in 2024, then soared by 88.88% to -$638,000 in 2025.
- Its EBIAT was -$638,000 in Q3 2025, compared to -$3.2 million in Q2 2025 and -$1.2 million in Q1 2025.